Alcon AG | ALC - Srodki Pieniężne I Ekwiwalent





Srodki Pieniężne I Ekwiwalent Zmiana Data
AstraZeneca USD 7.56B 1.85B 2026-03
Bayer EUR 6.67B 774M 2025-12
Essilor EUR 3.54B 758M 2025-12
Fresenius EUR 1.31B 81M 2025-12
Fresenius Medical Care EUR 1.24B 343.37M 2026-03
GlaxoSmithKline GBP 3.44B 292M 2026-03
GRIFOLS EUR 801M 242.31M 2025-12
Lonza CHF 719M 188M 2025-12
Merck EUR 2.33B 77M 2025-12
Novartis USD 6.88B 4.56B 2026-03
Philips EUR 2.79B 882M 2025-12
Roche Holding CHF 7.55B 579M 2025-06
Sanofi EUR 7.66B 1.25B 2025-12
Sonova Holding CHF 413.9M 134.3M 2023-06
UCB EUR 1.57B 1.14B 2024-12